Understanding the Menstrual Cycle and Hormonal Control: The Clinical Embryologist's Perspective

Let's understand the menstrual cycle and hormonal control from the clinical embryologist's perspective. Every IVF protocol is a calculated manipulation of the natural menstrual cycle. To modify a system intelligently, you must first understand it completely. This guide walks through every hormonal event of the menstrual cycle — and at each step, reveals exactly what the clinical embryologist is watching for, measuring, or acting on.

1. The Hormonal Control System — A Quick Recap

The HPG (Hypothalamic-Pituitary-Gonadal) axis is the master regulator of reproduction. Two types of feedback mechanisms within this axis are exploited by IVF protocols.

In negative feedback, rising oestrogen and progesterone signal the hypothalamus and pituitary to reduce GnRH, FSH, and LH secretion. This is why only one dominant follicle grows naturally — rising oestradiol suppresses FSH, causing all other follicles to regress.

In positive feedback, when oestradiol reaches a critical high threshold (above ~200 pg/mL for 24–48 hours), it switches from suppressing to triggering a massive LH surge from the pituitary — causing ovulation.

In IVF, multiple follicles produce far more oestradiol than one follicle would, risking a premature LH surge. GnRH antagonists or agonist down-regulation are used to block this — giving the embryologist full control over timing.

2. The Menstrual Cycle Phase by Phase

Days 1–5 — Menstruation and Early Follicle Recruitment

The corpus luteum from the previous cycle degenerates, progesterone and oestrogen fall, and the endometrial functional layer sheds. Prostaglandins trigger myometrial contractions — explaining why NSAIDs relieve period pain. Rising FSH begins recruiting the next cohort of 5–15 antral follicles.

In an IVF cycle, Day 2 or 3 is the standard start date. Baseline blood tests (FSH, LH, oestradiol, AMH) and a transvaginal ultrasound (antral follicle count) are performed. If all is clear, FSH injections begin — amplifying the natural signal to grow more follicles than natural selection would normally allow.

Days 6–12 — The Follicular Phase

As follicles grow and produce increasing oestradiol, FSH is suppressed via negative feedback. Only the dominant follicle — having the most FSH receptors — continues growing. All smaller follicles undergo atresia. Oestradiol drives endometrial proliferation, thickening it from 2–3mm to 7–10mm with a characteristic trilaminar (triple-line) pattern visible on ultrasound.

Oestradiol production requires the two-cell, two-gonadotrophin model: theca cells respond to LH to produce androgens, which granulosa cells convert to oestradiol via aromatase under FSH stimulation. Neither cell alone can produce oestradiol — this is why some IVF medications such as Menopur contain both FSH and LH.

During IVF stimulation, monitoring appointments track follicle size (target: 3+ follicles above 17mm), serum oestradiol (~150–200 pg/mL per mature follicle), and serum LH to detect any premature surge.

Day ~14 — The LH Surge and Ovulation

Peak oestradiol triggers kisspeptin neurons in the hypothalamus, driving a massive GnRH release and a tenfold LH surge. This triggers final oocyte maturation (meiosis I completion, first polar body extrusion, MII arrest), cumulus expansion, prostaglandin-driven follicle wall weakening, and rupture approximately 36–40 hours after the surge begins.

In IVF, the trigger shot — hCG (Ovitrelle) or a GnRH agonist (Lucrin) — mimics this surge. Egg retrieval is scheduled exactly 34–36 hours later, timed so oocytes have completed final maturation but follicles have not yet ruptured.

Days 15–28 — The Luteal Phase and Implantation Window

The ruptured follicle becomes the corpus luteum, producing progesterone. Progesterone transforms the proliferative endometrium into a secretory state — glands become tortuous and glycogen-rich, cervical mucus becomes thick and impenetrable, and the uterine muscle relaxes to prevent embryo expulsion.

The implantation window falls on Days 20–24, when pinopodes are maximally expressed, integrin αvβ3 peaks, and LIF (Leukaemia Inhibitory Factor) creates a permissive environment for embryo attachment. Outside this window, even a chromosomally normal embryo will fail to implant.

If no pregnancy occurs, the corpus luteum degenerates, progesterone falls, and menstruation begins. In IVF, because egg retrieval disrupts the corpus luteum, vaginal progesterone (luteal support) is mandatory from the day after retrieval through to the 12-week pregnancy test.

3. IVF Protocols Mapped to the Natural Cycle

The GnRH Antagonist Protocol

This is the most widely used modern IVF protocol — shorter, gentler, and with a lower OHSS risk. FSH injections begin on Day 2–3. A GnRH antagonist (Cetrotide or Orgalutran) is added when the lead follicle reaches 14mm, immediately blocking pituitary LH receptors and preventing any premature surge. When follicles reach 17–22mm, the trigger shot is given and egg collection follows 34–36 hours later.

The GnRH Agonist Long Protocol

A GnRH agonist (Lucrin or Decapeptyl) is started in the mid-luteal phase of the prior cycle. It initially causes a brief FSH and LH flare, then with continuous use, the pituitary GnRH receptors become desensitised and downregulated — effectively switching off the HPG axis. FSH injections are then started in a new cycle with no risk of premature LH surge. This protocol is longer (4–6 weeks total) but offers very precise cycle scheduling. It is preferred for endometriosis patients and good responders requiring careful control.

4. When the Cycle Goes Wrong — Anovulation

PCOS is the most common cause, characterised by high LH, high androgens, high AMH, and multiple small follicles. It is managed with letrozole for ovulation induction, careful IVF stimulation, and a freeze-all strategy to avoid OHSS.

Hypothalamic amenorrhoea presents with low GnRH, FSH, LH, and oestradiol due to weight loss, over-exercise, or chronic stress. It requires weight restoration and injectable FSH plus LH stimulation.

Premature ovarian insufficiency shows very high FSH above 25 IU/L, very low AMH, and low oestradiol before age 40. Own-egg IVF is usually unsuccessful; donor egg IVF has excellent outcomes.

Hyperprolactinaemia suppresses GnRH via elevated prolactin. Cabergoline often restores natural ovulation without needing IVF.

5. Endometrial Synchrony — The Other Half of IVF Success

A Day 5 blastocyst must be transferred into an endometrium that is on Day 5 of progesterone exposure — within the mid-secretory implantation window. Being off by even 1–2 days drops implantation rates dramatically.

The ERA (Endometrial Receptivity Analysis) test addresses this in recurrent implantation failure cases. A biopsy is taken in a mock cycle on Day 5 of progesterone supplementation and analysed transcriptomically. It identifies whether a patient's window is pre-receptive, receptive, or post-receptive — and provides personalised transfer timing. Approximately 25–30% of women have a displaced implantation window. ERA is not recommended for routine IVF use, only for patients with two or more failed transfers of good-quality embryos.

6. Key Hormone Reference Values in IVF Monitoring

FSH on Day 2–3 should be 3–10 IU/L. Above 15 IU/L suggests poor ovarian reserve and may require higher stimulation doses. LH during stimulation should stay below 10 IU/L — a rise above 10–15 IU/L signals a premature surge risk. Oestradiol above 5,000 pg/mL indicates high OHSS risk and warrants a freeze-all strategy. Progesterone above 1.5 ng/mL during stimulation indicates premature luteinisation and may also require freezing all embryos. AMH between 1.0–3.5 ng/mL is normal; below 0.5 indicates a poor prognosis and above 5 signals OHSS risk, with above 10 suggesting likely PCOS.

High-Yield Revision Points

Negative feedback keeps the cycle orderly — oestradiol and progesterone suppress FSH and LH throughout most of the cycle. Positive feedback at peak oestradiol triggers the LH surge via kisspeptin neurons in the hypothalamic AVPV nucleus. The two-cell two-gonadotrophin model explains oestradiol production — theca cells plus LH produce androgens; granulosa cells plus FSH convert androgens to oestradiol via aromatase. The LH surge peaks at 40–200 IU/L and triggers ovulation 36–40 hours later. The trigger shot (hCG or GnRH agonist) mimics this surge, with egg retrieval timed exactly 34–36 hours after. The implantation window falls on Days 20–24 of a 28-day cycle. Luteal support is mandatory in all IVF cycles. The antagonist protocol is shorter with lower OHSS risk; the long agonist protocol offers tighter control for complex cases. E2 above 5,000 pg/mL, LH above 10–15 IU/L, or progesterone above 1.5 ng/mL during stimulation are all action triggers requiring immediate clinical review.

Conclusion

The menstrual cycle is a precisely choreographed hormonal performance that the clinical embryologist must understand at every level — the molecules, the feedback mechanisms, the timing, and the clinical measurement points. Every IVF decision flows directly from this biology. The clinician reads the hormones; the embryologist reads the embryos. Together, they work to replicate the extraordinary synchrony that the natural cycle achieves silently, every month, in every reproductively healthy woman.

---

Disclaimer: This blog is for educational purposes. Content is developed for aspiring embryology students and reviewed by faculty at GRACE Embryology Institution.